Medical Marijuana for Spinal Cord Disease or Injury in Ohio

Spinal cord disease and injury represent one of the qualifying condition categories in Ohio’s medical marijuana program where the symptom burden is often severe, the limitations of conventional treatment are well recognized, and patient interest in alternative options is consistently high. For Ohio residents living with the chronic consequences of spinal cord damage — whether from trauma, disease, or other causes — this page explains how the qualifying condition works, what the research shows, and how to approach the evaluation process.

Does Spinal Cord Disease or Injury Qualify for Medical Marijuana in Ohio?

Yes. Spinal cord disease or injury is explicitly listed as a qualifying condition under Ohio Revised Code Section 3796.01. Ohio law covers both spinal cord disease — such as spinal cord compression, transverse myelitis, or other disease processes affecting the spinal cord — and traumatic spinal cord injury.

Ohio does not restrict this qualifier to a specific injury level, completeness classification, or time since injury. A physician holding a Certificate to Recommend (CTR) issued by the State Medical Board of Ohio evaluates whether your documented condition and symptom picture support a medical marijuana recommendation.

What Symptoms Do Spinal Cord Patients Most Commonly Address?

Spinal cord damage — whether from trauma or disease — produces a range of chronic complications that are frequently inadequately managed by standard pharmacological approaches. In reviewing the research and patient-reported outcome data, the symptoms most consistently associated with medical marijuana consideration in this population are:

Spasticity

Spasticity — involuntary muscle stiffness and spasms — is one of the most disabling chronic complications of spinal cord damage. The National Academies of Sciences, Engineering, and Medicine identified substantial evidence that oral cannabinoids improve patient-reported spasticity symptoms — a finding that originated in MS research but is consistently extended to other causes of central spasticity including spinal cord injury.

A recent placebo-controlled double-blind crossover trial published through PMC specifically examined THC:CBD oil in 16 patients with chronic spinal cord injuries and severe treatment-refractory spasticity. Patients receiving the active THC:CBD oil reported significantly improved self-reported spasticity ratings compared to placebo — representing one of the most rigorously designed SCI-specific cannabis trials to date.

Research published through PMC found that among spinal cord injury patients using cannabis, 59% reported a positive effect on pain and spasticity — with a meta-analysis cited in the same research finding that cannabis users experienced a 30% greater reduction in chronic pain compared to placebo alongside improvements in spasticity symptoms.

Neuropathic Pain

Central neuropathic pain is among the most treatment-resistant consequences of spinal cord damage. As reviewed in research published through PMC examining cannabis-based medicine for neuropathic pain and spasticity in both MS and SCI patients, evidence for cannabinoids in central neuropathic pain has shown limited and conflicting results in controlled trials — with nabiximols studies in particular reporting negative outcomes for neuropathic pain in some trials while patient-reported surveys consistently show high rates of subjective pain relief.

This gap between objective trial results and patient-reported experience is a consistent pattern in SCI neuropathic pain research — and represents an honest picture worth understanding before pursuing an evaluation.

A review published through PMC examining cannabinoids for spinal disorders found that SCI is a devastating condition resulting in significant functional deficits and chronic neuropathic pain — and that while the evidence base for cannabinoids in this context is developing, the symptom burden and limitations of conventional treatment make it a clinically relevant area of investigation.

Sleep, Mood, and Quality of Life

Beyond spasticity and pain, research published through PMC found that regular cannabis use among SCI patients was associated with improved sleep, decreased depression and anxiety, and improved social interaction — all contributing to better quality of life outcomes. These non-pain benefits are reported consistently across SCI patient surveys and represent a meaningful dimension of what medical marijuana may offer this population beyond direct pain or spasticity management.

Opioid Use in Spinal Cord Injury Patients

Many Ohio spinal cord injury patients are managing chronic pain with opioids — often for years following their injury. Research has found that some SCI patients using cannabis were able to reduce or discontinue prescribed narcotic medications. A qualitative study noted that cannabis use allowed some individuals with SCI to discontinue their prescribed anxiety and narcotic medications.

For Ohio SCI patients currently using opioids for pain management, our guide on reducing opioid use with medical marijuana for back pain in Ohio covers the relevant research on opioid reduction — much of which applies directly to SCI-related chronic pain as well.

What Documentation Do Ohio Spinal Cord Patients Need?

Ohio-certified physicians evaluating spinal cord disease or injury patients look for documentation that establishes the diagnosis and captures the chronic symptom picture:

Physician or specialist records confirming the spinal cord injury or disease diagnosis — including injury level, completeness classification, and time since injury for traumatic SCI patients, or diagnosis and disease course documentation for spinal cord disease patients. Records showing current spasticity management — including antispasticity medications such as baclofen, tizanidine, or dantrolene and their outcomes. Pain management history — particularly relevant if opioids or other controlled substances have been used for chronic neuropathic pain. Current medication list for the OARRS check. Symptom impact documentation noting how spasticity, pain, sleep disruption, or mood disturbance affects daily functioning.

Getting Your Ohio Spinal Cord Evaluation

The telemedicine format of Ohio’s evaluation is particularly practical for spinal cord injury and disease patients whose mobility challenges make in-person clinic visits difficult or impossible. The entire process is completed online — a short intake form followed by a brief video consultation with an Ohio-certified physician reviewing your diagnosis, symptom history, and current medications.

If approved, your recommendation is submitted directly to the Ohio Patient & Caregiver Registry and your digital card is activated via email — valid at any licensed Ohio dispensary statewide. Caregivers may participate in the evaluation call if needed. If the physician determines you do not qualify there is no charge.

If you are an Ohio spinal cord disease or injury patient and want to find out whether you qualify for the medical marijuana program, you can schedule your evaluation here.

Frequently Asked Questions

Sources

• Ohio Revised Code Section 3796.01 — Qualifying Medical Conditions — Ohio Laws
• State Medical Board of Ohio — Medical Marijuana Program — med.ohio.gov
• Ohio Patient & Caregiver Registry — Ohio Division of Cannabis Control
• Medical Cannabis Improved Self-Reported Spasticity in Chronic Spinal Cord Injury — PMC / NIH
• Self-Reported Effects of Cannabis on Neuropathic Pain in Spinal Cord Injury — PMC / NIH
• Cannabis-Based Medicine for Neuropathic Pain and Spasticity in MS and SCI — PMC / NIH
• Cannabinoids in the Treatment of Spinal Disorders — PMC / NIH